Filing Details

Accession Number:
0000919574-18-004815
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-18 13:55:31
Reporting Period:
2018-07-16
Accepted Time:
2018-07-18 13:55:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1634432 Strongbridge Biopharma Plc SBBP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325713 Bruce Kovner C/O Caxton Corporation
731 Alexander Road, Building #2
Princeton NJ 08540
No No Yes No
1388551 Caxton Corp 731 Alexander Road
Building #2
Princeton NJ 08540
No No Yes No
1576081 Cdk Associates, L.l.c. C/O Caxton Corporation
731 Alexander Road, Building #2
Princeton NJ 08540
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares, $0.01 Par Value Acquisiton 2018-07-16 11,200 $4.97 5,409,234 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares represent (a) 5,113,633 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 295,601 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 3 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.